+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Generic Drugs Market 2023-2027

  • PDF Icon

    Report

  • 167 Pages
  • December 2022
  • Region: Global
  • TechNavio
  • ID: 5459513
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The generic drugs market is poised to grow by $176.25 bn during 2023-2027, accelerating at a CAGR of 7.11% during the forecast period. The report on the generic drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by low-cost alternatives, increased outsourcing of drug discovery and development, and rising drug patent expirations.

The generic drugs market is segmented as below:

By Route Of Administration

  • Oral
  • Injectables
  • Topical
  • Inhalers

By Type

  • Small-molecule generics
  • Biosimilars

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the advent of RPA as one of the prime reasons driving the generic drugs market growth during the next few years. Also, rising m and a and hospital-owned generics will lead to sizable demand in the market.

The report on the generic drugs market covers the following areas:

  • Generic drugs market sizing
  • Generic drugs market forecast
  • Generic drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading generic drugs market vendors that include Abbott Laboratories, Amgen Inc., Aurobindo Pharma Ltd., Baxter International Inc., Biocon Ltd., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Endo International Plc, Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., Viatris Inc., Sun Pharmaceutical Industries Ltd., Lupin Ltd., Cadila Pharmaceuticals Ltd., and Cipla Ltd. Also, the generic drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global generic drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global generic drugs market 2017 - 2021 ($ billion)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
4.3 Route of administration Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Route of administration Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Small-molecule generics - Market size and forecast 2022-2027
Exhibit 34: Chart on Small-molecule generics - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on Small-molecule generics - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on Small-molecule generics - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Small-molecule generics - Year-over-year growth 2022-2027 (%)
6.4 Biosimilars - Market size and forecast 2022-2027
Exhibit 38: Chart on Biosimilars - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Biosimilars - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Biosimilars - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Biosimilars - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ billion)
7 Market Segmentation by Route of Administration
7.1 Market segments
Exhibit 43: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibit 44: Data Table on Route of Administration - Market share 2022-2027 (%)
7.2 Comparison by Route of Administration
Exhibit 45: Chart on Comparison by Route of Administration
Exhibit 46: Data Table on Comparison by Route of Administration
7.3 Oral - Market size and forecast 2022-2027
Exhibit 47: Chart on Oral - Market size and forecast 2022-2027 ($ billion)
Exhibit 48: Data Table on Oral - Market size and forecast 2022-2027 ($ billion)
Exhibit 49: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Oral - Year-over-year growth 2022-2027 (%)
7.4 Injectables - Market size and forecast 2022-2027
Exhibit 51: Chart on Injectables - Market size and forecast 2022-2027 ($ billion)
Exhibit 52: Data Table on Injectables - Market size and forecast 2022-2027 ($ billion)
Exhibit 53: Chart on Injectables - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Injectables - Year-over-year growth 2022-2027 (%)
7.5 Topical - Market size and forecast 2022-2027
Exhibit 55: Chart on Topical - Market size and forecast 2022-2027 ($ billion)
Exhibit 56: Data Table on Topical - Market size and forecast 2022-2027 ($ billion)
Exhibit 57: Chart on Topical - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Topical - Year-over-year growth 2022-2027 (%)
7.6 Inhalers - Market size and forecast 2022-2027
Exhibit 59: Chart on Inhalers - Market size and forecast 2022-2027 ($ billion)
Exhibit 60: Data Table on Inhalers - Market size and forecast 2022-2027 ($ billion)
Exhibit 61: Chart on Inhalers - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Inhalers - Year-over-year growth 2022-2027 (%)
7.7 Market opportunity by Route of Administration
Exhibit 63: Market opportunity by Route of Administration ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 65: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 67: Chart on Geographic comparison
Exhibit 68: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 89: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 90: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 India - Market size and forecast 2022-2027
Exhibit 101: Chart on India - Market size and forecast 2022-2027 ($ billion)
Exhibit 102: Data Table on India - Market size and forecast 2022-2027 ($ billion)
Exhibit 103: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on India - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 105: Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 106: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 108: Overview on factors of disruption
11.4 Industry risks
Exhibit 109: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 110: Vendors covered
12.2 Market positioning of vendors
Exhibit 111: Matrix on vendor position and classification
12.3 Amgen Inc.
Exhibit 112: Amgen Inc. - Overview
Exhibit 113: Amgen Inc. - Product/Service
Exhibit 114: Amgen Inc. - Key offerings
12.4 Aurobindo Pharma Ltd.
Exhibit 115: Aurobindo Pharma Ltd. - Overview
Exhibit 116: Aurobindo Pharma Ltd. - Product/Service
Exhibit 117: Aurobindo Pharma Ltd. - Key offerings
12.5 Baxter International Inc.
Exhibit 118: Baxter International Inc. - Overview
Exhibit 119: Baxter International Inc. - Business segments
Exhibit 120: Baxter International Inc. - Key news
Exhibit 121: Baxter International Inc. - Key offerings
Exhibit 122: Baxter International Inc. - Segment focus
12.6 Biocon Ltd.
Exhibit 123: Biocon Ltd. - Overview
Exhibit 124: Biocon Ltd. - Business segments
Exhibit 125: Biocon Ltd. - Key offerings
Exhibit 126: Biocon Ltd. - Segment focus
12.7 Cadila Pharmaceuticals Ltd.
Exhibit 127: Cadila Pharmaceuticals Ltd. - Overview
Exhibit 128: Cadila Pharmaceuticals Ltd. - Product/Service
Exhibit 129: Cadila Pharmaceuticals Ltd. - Key offerings
12.8 Cipla Ltd.
Exhibit 130: Cipla Ltd. - Overview
Exhibit 131: Cipla Ltd. - Business segments
Exhibit 132: Cipla Ltd. - Key news
Exhibit 133: Cipla Ltd. - Key offerings
Exhibit 134: Cipla Ltd. - Segment focus
12.9 Dr Reddys Laboratories Ltd.
Exhibit 135: Dr Reddys Laboratories Ltd. - Overview
Exhibit 136: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 137: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 138: Dr Reddys Laboratories Ltd. - Segment focus
12.10 Fresenius SE and Co. KGaA
Exhibit 139: Fresenius SE and Co. KGaA - Overview
Exhibit 140: Fresenius SE and Co. KGaA - Business segments
Exhibit 141: Fresenius SE and Co. KGaA - Key news
Exhibit 142: Fresenius SE and Co. KGaA - Key offerings
Exhibit 143: Fresenius SE and Co. KGaA - Segment focus
12.11 Merck and Co. Inc.
Exhibit 144: Merck and Co. Inc. - Overview
Exhibit 145: Merck and Co. Inc. - Business segments
Exhibit 146: Merck and Co. Inc. - Key news
Exhibit 147: Merck and Co. Inc. - Key offerings
Exhibit 148: Merck and Co. Inc. - Segment focus
12.12 Novartis AG
Exhibit 149: Novartis AG - Overview
Exhibit 150: Novartis AG - Business segments
Exhibit 151: Novartis AG - Key offerings
Exhibit 152: Novartis AG - Segment focus
12.13 Pfizer Inc.
Exhibit 153: Pfizer Inc. - Overview
Exhibit 154: Pfizer Inc. - Product/Service
Exhibit 155: Pfizer Inc. - Key news
Exhibit 156: Pfizer Inc. - Key offerings
12.14 Sanofi SA
Exhibit 157: Sanofi SA - Overview
Exhibit 158: Sanofi SA - Business segments
Exhibit 159: Sanofi SA - Key news
Exhibit 160: Sanofi SA - Key offerings
Exhibit 161: Sanofi SA - Segment focus
12.15 Sun Pharmaceutical Industries Ltd.
Exhibit 162: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 163: Sun Pharmaceutical Industries Ltd. - Product/Service
Exhibit 164: Sun Pharmaceutical Industries Ltd. - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
Exhibit 165: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 166: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 167: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 168: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 169: Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Viatris Inc.
Exhibit 170: Viatris Inc. - Overview
Exhibit 171: Viatris Inc. - Business segments
Exhibit 172: Viatris Inc. - Key offerings
Exhibit 173: Viatris Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 174: Inclusions checklist
Exhibit 175: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 176: Currency conversion rates for US$
13.4 Research methodology
Exhibit 177: Research methodology
Exhibit 178: Validation techniques employed for market sizing
Exhibit 179: Information sources
13.5 List of abbreviations
Exhibit 180: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global generic drugs market 2017 - 2021 ($ billion)
Exhibits 19: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
Exhibits 20: Historic Market Size - Route of administration Segment 2017 - 2021 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Type - Market share 2022-2027 (%)
Exhibits 31: Data Table on Type - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on Small-molecule generics - Market size and forecast 2022-2027 ($ billion)
Exhibits 35: Data Table on Small-molecule generics - Market size and forecast 2022-2027 ($ billion)
Exhibits 36: Chart on Small-molecule generics - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Small-molecule generics - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Biosimilars - Market size and forecast 2022-2027 ($ billion)
Exhibits 39: Data Table on Biosimilars - Market size and forecast 2022-2027 ($ billion)
Exhibits 40: Chart on Biosimilars - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Biosimilars - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by Type ($ billion)
Exhibits 43: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits 44: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits 45: Chart on Comparison by Route of Administration
Exhibits 46: Data Table on Comparison by Route of Administration
Exhibits 47: Chart on Oral - Market size and forecast 2022-2027 ($ billion)
Exhibits 48: Data Table on Oral - Market size and forecast 2022-2027 ($ billion)
Exhibits 49: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibits 50: Data Table on Oral - Year-over-year growth 2022-2027 (%)
Exhibits 51: Chart on Injectables - Market size and forecast 2022-2027 ($ billion)
Exhibits 52: Data Table on Injectables - Market size and forecast 2022-2027 ($ billion)
Exhibits 53: Chart on Injectables - Year-over-year growth 2022-2027 (%)
Exhibits 54: Data Table on Injectables - Year-over-year growth 2022-2027 (%)
Exhibits 55: Chart on Topical - Market size and forecast 2022-2027 ($ billion)
Exhibits 56: Data Table on Topical - Market size and forecast 2022-2027 ($ billion)
Exhibits 57: Chart on Topical - Year-over-year growth 2022-2027 (%)
Exhibits 58: Data Table on Topical - Year-over-year growth 2022-2027 (%)
Exhibits 59: Chart on Inhalers - Market size and forecast 2022-2027 ($ billion)
Exhibits 60: Data Table on Inhalers - Market size and forecast 2022-2027 ($ billion)
Exhibits 61: Chart on Inhalers - Year-over-year growth 2022-2027 (%)
Exhibits 62: Data Table on Inhalers - Year-over-year growth 2022-2027 (%)
Exhibits 63: Market opportunity by Route of Administration ($ billion)
Exhibits 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 65: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 67: Chart on Geographic comparison
Exhibits 68: Data Table on Geographic comparison
Exhibits 69: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits 70: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits 71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 73: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits 74: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 77: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits 78: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 85: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits 86: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits 87: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 88: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 89: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits 90: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 93: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits 94: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits 95: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 96: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 97: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits 98: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits 99: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 101: Chart on India - Market size and forecast 2022-2027 ($ billion)
Exhibits 102: Data Table on India - Market size and forecast 2022-2027 ($ billion)
Exhibits 103: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibits 104: Data Table on India - Year-over-year growth 2022-2027 (%)
Exhibits 105: Market opportunity By Geographical Landscape ($ billion)
Exhibits 106: Impact of drivers and challenges in 2022 and 2027
Exhibits 107: Overview on Criticality of inputs and Factors of differentiation
Exhibits 108: Overview on factors of disruption
Exhibits 109: Impact of key risks on business
Exhibits 110: Vendors covered
Exhibits 111: Matrix on vendor position and classification
Exhibits 112: Amgen Inc. - Overview
Exhibits 113: Amgen Inc. - Product/Service
Exhibits 114: Amgen Inc. - Key offerings
Exhibits 115: Aurobindo Pharma Ltd. - Overview
Exhibits 116: Aurobindo Pharma Ltd. - Product/Service
Exhibits 117: Aurobindo Pharma Ltd. - Key offerings
Exhibits 118: Baxter International Inc. - Overview
Exhibits 119: Baxter International Inc. - Business segments
Exhibits 120: Baxter International Inc. - Key news
Exhibits 121: Baxter International Inc. - Key offerings
Exhibits 122: Baxter International Inc. - Segment focus
Exhibits 123: Biocon Ltd. - Overview
Exhibits 124: Biocon Ltd. - Business segments
Exhibits 125: Biocon Ltd. - Key offerings
Exhibits 126: Biocon Ltd. - Segment focus
Exhibits 127: Cadila Pharmaceuticals Ltd. - Overview
Exhibits 128: Cadila Pharmaceuticals Ltd. - Product/Service
Exhibits 129: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits 130: Cipla Ltd. - Overview
Exhibits 131: Cipla Ltd. - Business segments
Exhibits 132: Cipla Ltd. - Key news
Exhibits 133: Cipla Ltd. - Key offerings
Exhibits 134: Cipla Ltd. - Segment focus
Exhibits 135: Dr Reddys Laboratories Ltd. - Overview
Exhibits 136: Dr Reddys Laboratories Ltd. - Business segments
Exhibits 137: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits 138: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits 139: Fresenius SE and Co. KGaA - Overview
Exhibits 140: Fresenius SE and Co. KGaA - Business segments
Exhibits 141: Fresenius SE and Co. KGaA - Key news
Exhibits 142: Fresenius SE and Co. KGaA - Key offerings
Exhibits 143: Fresenius SE and Co. KGaA - Segment focus
Exhibits 144: Merck and Co. Inc. - Overview
Exhibits 145: Merck and Co. Inc. - Business segments
Exhibits 146: Merck and Co. Inc. - Key news
Exhibits 147: Merck and Co. Inc. - Key offerings
Exhibits 148: Merck and Co. Inc. - Segment focus
Exhibits 149: Novartis AG - Overview
Exhibits 150: Novartis AG - Business segments
Exhibits 151: Novartis AG - Key offerings
Exhibits 152: Novartis AG - Segment focus
Exhibits 153: Pfizer Inc. - Overview
Exhibits 154: Pfizer Inc. - Product/Service
Exhibits 155: Pfizer Inc. - Key news
Exhibits 156: Pfizer Inc. - Key offerings
Exhibits 157: Sanofi SA - Overview
Exhibits 158: Sanofi SA - Business segments
Exhibits 159: Sanofi SA - Key news
Exhibits 160: Sanofi SA - Key offerings
Exhibits 161: Sanofi SA - Segment focus
Exhibits 162: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 163: Sun Pharmaceutical Industries Ltd. - Product/Service
Exhibits 164: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 165: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 166: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 167: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 168: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 169: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 170: Viatris Inc. - Overview
Exhibits 171: Viatris Inc. - Business segments
Exhibits 172: Viatris Inc. - Key offerings
Exhibits 173: Viatris Inc. - Segment focus
Exhibits 174: Inclusions checklist
Exhibits 175: Exclusions checklist
Exhibits 176: Currency conversion rates for US$
Exhibits 177: Research methodology
Exhibits 178: Validation techniques employed for market sizing
Exhibits 179: Information sources
Exhibits 180: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global generic drugs market: Abbott Laboratories, Amgen Inc., Aurobindo Pharma Ltd., Baxter International Inc., Biocon Ltd., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Endo International Plc, Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., Viatris Inc., Sun Pharmaceutical Industries Ltd., Lupin Ltd., Cadila Pharmaceuticals Ltd., and Cipla Ltd.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is advent of RPA.`

According to the report, one of the major drivers for this market is the low-cost alternatives.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Amgen Inc.
  • Aurobindo Pharma Ltd.
  • Baxter International Inc.
  • Biocon Ltd.
  • Dr Reddys Laboratories Ltd.
  • Eli Lilly and Co.
  • Endo International Plc
  • Fresenius SE and Co. KGaA
  • GlaxoSmithKline Plc
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Lupin Ltd.
  • Cadila Pharmaceuticals Ltd.
  • Cipla Ltd.